EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Catalytic Effect of Amyloid-β on Native Tau Aggregation at Physiologically Relevant Concentrations

Rakhi Chowdhury iD, Apu Chandra Das iD, Ruan van Deventer, Luda S Shlyakhtenko, Yuri L Lyubchenko iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262412128 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Rakhi Chowdhury und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, University of Nebraska Medical Center, 4040 Emile Street, Omaha, NE 68198-6120, USA. Hauptthemen laut MEDLINE: tau Proteins, Amyloid beta-Peptides, Protein Aggregates, Peptide Fragments. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIH HHS, NIH/NIGMS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD) is characterized by the accumulation and aggregation of tau and amyloid-β (Aβ). The pathophysiology and progression of AD are facilitated by the neurotoxic effects of these aggregated proteins, resulting in neurodegeneration and memory loss. In this context, the interaction between tau and Aβ42 is considered, but the mechanism underlying their pathogenic interplay remains unclear. Here, we addressed this question by studying the aggregation of full-length, unmodified tau and Aβ42 at physiologically low concentrations using atomic force microscopy (AFM). AFM imaging and data analyses demonstrate an increase in tau aggregation in the presence of Aβ42, characterized by increased sizes and number of aggregates. Importantly, tau aggregation occurs without the need for phosphorylation or any other post-translational changes. The analysis of the data demonstrates that tau and Aβ42 form co-aggregates, with no visible accumulation of Aβ42 aggregates alone. Given that the catalysis of tau aggregation by Aβ42 is observed at physiological low nanomolar concentrations of Aβ42, the finding suggests that such aggregation catalysis of tau by Aβ42 can be a molecular mechanism underlying the pathological tau aggregation process associated with the onset and development of Alzheimer’s disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

tau ProteinsAmyloid beta-PeptidesProtein AggregatesPeptide FragmentsProtein Aggregation, PathologicalHumansMicroscopy, Atomic ForceAlzheimer DiseasePhosphorylation

Stichwörter der Autor:innen

AFM imagingAlzheimer’s diseaseaggregationamyloid betatau

Substanzen

tau ProteinsAmyloid beta-PeptidesProtein AggregatesPeptide Fragmentsamyloid beta-protein (1-42)

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, University of Nebraska Medical Center, 4040 Emile Street, Omaha, NE 68198-6120, USA.
  • Department of Biostatistics, University of Nebraska Medical Center, 4040 Emile Street, Omaha, NE 68198-6120, USA.

ORCID-Profile: Rakhi Chowdhury, Apu Chandra Das, Yuri L Lyubchenko

Förderung

  • NIGMS NIH HHS
  • NIH HHS
  • NIH/NIGMS

Zitieren

APA

Chowdhury, R., Das, A. C., van Deventer, R., Shlyakhtenko, L. S., & Lyubchenko, Y. L. (2025). Catalytic Effect of Amyloid-β on Native Tau Aggregation at Physiologically Relevant Concentrations. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262412128

Vancouver

Chowdhury R, Das AC, van Deventer R, Shlyakhtenko LS, Lyubchenko YL. Catalytic Effect of Amyloid-β on Native Tau Aggregation at Physiologically Relevant Concentrations. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262412128

BibTeX
@article{Chowdhury2025,
  author = {Chowdhury, Rakhi and Das, Apu Chandra and van Deventer, Ruan and Shlyakhtenko, Luda S and Lyubchenko, Yuri L},
  title = {Catalytic Effect of Amyloid-β on Native Tau Aggregation at Physiologically Relevant Concentrations},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262412128}
}
Kostenlos starten →